Matthew Gordon Katcoff

Array ( [id] => 20497781 [patent_doc_number] => 20260027238 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-01-29 [patent_title] => CAPSID POLYPEPTIDES AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 19/342217 [patent_app_country] => US [patent_app_date] => 2025-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 99933 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19342217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20136464 [patent_doc_number] => 20250243508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-31 [patent_title] => PRODUCTION OF VIRUS VECTOR PLASMID IN BACILLUS SUBTILIS [patent_app_type] => utility [patent_app_number] => 19/042220 [patent_app_country] => US [patent_app_date] => 2025-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36202 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19042220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20578758 [patent_doc_number] => 12571001 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-03-10 [patent_title] => Baculovirus vector and use thereof in preparation of recombinant adeno-associated virus (rAAV) in insect cell [patent_app_type] => utility [patent_app_number] => 18/948625 [patent_app_country] => US [patent_app_date] => 2024-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 22 [patent_no_of_words] => 2479 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18948625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20006027 [patent_doc_number] => 20250144249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-08 [patent_title] => METHODS USING SURFACE-EXPRESSIBLE ACTIVATABLE EPITOPES TO LOCALIZE AND/OR TREAT DISEASED CELLS [patent_app_type] => utility [patent_app_number] => 18/936497 [patent_app_country] => US [patent_app_date] => 2024-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38819 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18936497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19860829 [patent_doc_number] => 20250099615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-27 [patent_title] => COMPOSITIONS FOR TREATING CANCER [patent_app_type] => utility [patent_app_number] => 18/919103 [patent_app_country] => US [patent_app_date] => 2024-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37310 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18919103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19754744 [patent_doc_number] => 20250043309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-06 [patent_title] => ENGINEERED MUSCLE TARGETING COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 18/915615 [patent_app_country] => US [patent_app_date] => 2024-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 103112 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18915615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19961835 [patent_doc_number] => 12331323 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-06-17 [patent_title] => Composition for regulating production of fusion proteins [patent_app_type] => utility [patent_app_number] => 18/885902 [patent_app_country] => US [patent_app_date] => 2024-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18885902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19658747 [patent_doc_number] => 20240425812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-26 [patent_title] => HYPOVENTILATION PHYSICAL MODELS AND APPLICATIONS THEREOF [patent_app_type] => utility [patent_app_number] => 18/748156 [patent_app_country] => US [patent_app_date] => 2024-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15507 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18748156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19871481 [patent_doc_number] => 12264329 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-04-01 [patent_title] => Composition for regulating production of fusion proteins [patent_app_type] => utility [patent_app_number] => 18/738959 [patent_app_country] => US [patent_app_date] => 2024-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3334 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18738959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20466813 [patent_doc_number] => 12522846 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-13 [patent_title] => Adeno-associated virus capsid [patent_app_type] => utility [patent_app_number] => 18/646835 [patent_app_country] => US [patent_app_date] => 2024-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 47 [patent_no_of_words] => 4912 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18646835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20246834 [patent_doc_number] => 20250295703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-09-25 [patent_title] => TREATMENT AGENT FOR HAIR DAMAGE [patent_app_type] => utility [patent_app_number] => 18/612441 [patent_app_country] => US [patent_app_date] => 2024-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 886 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18612441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19265624 [patent_doc_number] => 20240209323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-27 [patent_title] => METHODS AND CELLULAR STRUCTURES [patent_app_type] => utility [patent_app_number] => 18/601343 [patent_app_country] => US [patent_app_date] => 2024-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28995 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18601343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19331303 [patent_doc_number] => 20240245733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-25 [patent_title] => PRESERVATION OF PANCREATIC ISLET GRAFTS IN THE EXTRAHEPATIC SPACE [patent_app_type] => utility [patent_app_number] => 18/435722 [patent_app_country] => US [patent_app_date] => 2024-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24608 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18435722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19187788 [patent_doc_number] => 20240166701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-23 [patent_title] => NON-TRANSGENE TRANSFECTION FOR THERAPEUTIC PURPOSES [patent_app_type] => utility [patent_app_number] => 18/427711 [patent_app_country] => US [patent_app_date] => 2024-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19080 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18427711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19020234 [patent_doc_number] => 20240076405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-07 [patent_title] => EXPRESSION VECTORS FOR IMMUNOGLOBULINS AND APPLICATIONS THEREOF [patent_app_type] => utility [patent_app_number] => 18/494117 [patent_app_country] => US [patent_app_date] => 2023-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9788 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18494117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19474087 [patent_doc_number] => 12104165 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-10-01 [patent_title] => Adeno-associated virus with engineered capsid [patent_app_type] => utility [patent_app_number] => 18/493663 [patent_app_country] => US [patent_app_date] => 2023-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 40 [patent_no_of_words] => 34295 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18493663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19580051 [patent_doc_number] => 12146151 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-11-19 [patent_title] => Cross-species compatible adeno-associated virus compositions and methods of use thereof [patent_app_type] => utility [patent_app_number] => 18/474506 [patent_app_country] => US [patent_app_date] => 2023-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 136 [patent_no_of_words] => 31646 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18474506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19166024 [patent_doc_number] => 11981914 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-05-14 [patent_title] => Recombinant adeno-associated virus vectors [patent_app_type] => utility [patent_app_number] => 18/372334 [patent_app_country] => US [patent_app_date] => 2023-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 30564 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18372334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19051267 [patent_doc_number] => 20240093236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-21 [patent_title] => RAPID HIGH THROUGHPUT SCREENING SYSTEM TO ASSESS POTENTIAL TREATMENTS FOR SPORADIC ALZHEIMER'S DISEASE [patent_app_type] => utility [patent_app_number] => 18/360217 [patent_app_country] => US [patent_app_date] => 2023-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21855 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18360217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20077761 [patent_doc_number] => 12351814 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-08 [patent_title] => Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells [patent_app_type] => utility [patent_app_number] => 18/351674 [patent_app_country] => US [patent_app_date] => 2023-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 69 [patent_no_of_words] => 12301 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18351674 [rel_patent_id] =>[rel_patent_doc_number] =>)